Possible immunological treatment for Type 1 diabetes in the 21 st century
Open Access
- 1 November 1997
- journal article
- review article
- Published by Wiley in Practical Diabetes International
- Vol. 14 (7) , 197-200
- https://doi.org/10.1002/pdi.1960140708
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- BCG Vaccination Prevents Insulin-Dependent Diabetes Mellitus (IDDM) in NOD Mice after Disease Acceleration with CyclophosphamideJournal of Autoimmunity, 1997
- Complexities in the Treatment of Autoimmune DiseaseScience, 1996
- Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in MiceScience, 1996
- Theory and Practice of Nicotinamide Trials in Pre-Type 1 DiabetesJournal of Pediatric Endocrinology and Metabolism, 1996
- Prevention of Autoimmune Diabetes in Nonobese Diabetic Female Mice by Treatment with Recombinant Glutamic Acid Decarboxylase (GAD 65)Clinical Immunology and Immunopathology, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Prevention of Diabetes and Insulitis by Neonatal Intrathymic Islet Administration in NOD MiceJournal of Autoimmunity, 1994
- Lessons Learned from Use of Cyclosporine for Insulin‐Dependent Diabetes MellitusAnnals of the New York Academy of Sciences, 1993
- Immunosuppressive therapy of autoimmune diseasesImmunology Today, 1993
- Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt miceDiabetes, 1992